StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Qiagen's EV/EBITDA was 17.5× on Nov 11, 2026, against 38.3× a year earlier. Over the last 5 years it ranged from 12.3× to 40.9×, with a median of 15.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.5×−18.6
2025Dec 31, 202536.1×+18.7
2024Dec 31, 202417.4×+2.6
2023Dec 29, 202314.8×−0.6
2022Dec 30, 202215.5×−9.8
2021Dec 31, 202125.2×−40.8
2020Dec 31, 202066.1×+46.8
2019Dec 31, 201919.2×−5.6
2018Dec 31, 201824.8×−1.8
2017Dec 29, 201726.7×+6.0
2016Dec 30, 201620.7×−0.5
2015Dec 31, 201521.2×−3.4
2014Dec 31, 201424.6×+7.4
2013Dec 31, 201317.1×−0.8
2012Dec 31, 201218.0×−2.0
2011Jan 31, 201119.9×−1.2
2010Dec 31, 201021.1×−2.6
2009Dec 31, 200923.7×–

More Qiagen figures

See a number that looks wrong?